Format

Send to

Choose Destination
See comment in PubMed Commons below
Transfus Apher Sci. 2006 Aug;35(1):5-17. Epub 2006 Aug 28.

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Author information

1
Navigant Biotechnologies Inc, Lakewood, CO 80215, USA. ray.goodrich@navigantbiotech.com

Abstract

The safety of blood transfusion is still threatened by contamination of blood products with a variety of pathogens such as viruses, bacteria and parasites. A novel pathogen reduction process for platelets and plasma products, the Mirasol PRT system, has been developed and is under clinical evaluation for its efficacy and safety. The Mirasol PRT process is based on riboflavin photochemistry. This manuscript reviews current progress and future trends.

PMID:
16935562
DOI:
10.1016/j.transci.2006.01.007
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center